The nurse is administering an estrogen blocker to a client diagnosed with advanced breast cancer. Which of the following side effects will the nurse caution the client regarding?
Tendon rupture
Phlebitis
Increase risk of lymphomas
Thromboembolic events
The Correct Answer is D
A. Tendon rupture: Tendon rupture is not a side effect associated with estrogen blockers.
B. Phlebitis: While thromboembolic events are a risk, phlebitis (inflammation of a vein) is not a typical concern.
C. Increased risk of lymphomas: Estrogen blockers are not known to increase the risk of lymphomas.
D. Thromboembolic events: Estrogen blockers, such as tamoxifen, are associated with an increased risk of thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism).
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is A
Explanation
A. Alcohol consumption: Metronidazole has a disulfiram-like reaction with alcohol, which can cause severe nausea, vomiting, flushing, and tachycardia. Clients should avoid alcohol during and for at least 48 hours after the completion of metronidazole therapy.
B. Tyramine-based foods: Avoiding tyramine-rich foods is important with certain MAOIs due to the risk of hypertensive crisis, not with metronidazole.
C. Apple Juice: There is no significant interaction between metronidazole and apple juice.
D. Soy beans: Soybeans do not have an interaction with metronidazole.
Correct Answer is B
Explanation
A. Clotting Factors: Epoetin alfa does not directly influence clotting factors.
B. Hemoglobin & hematocrit: Epoetin alfa is used to stimulate red blood cell production, which increases hemoglobin and hematocrit levels. Monitoring these values helps determine the drug’s therapeutic effectiveness in improving anemia associated with chronic renal disease.
C. Leukocyte Count: This medication primarily affects red blood cells, not white blood cells (leukocytes).
D. ALT & AST: These are liver function tests and are not related to the therapeutic effect of epoetin alfa.